Company · CIK 2044725

# Evommune, Inc.

| CIK | [2044725](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002044725) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | EVMN (NYSE) |
| First annual or quarterly report | 2025-12-11 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-295140 | Registered company Effective | 2026-04-17 | 2026-04-24 | 2 |
| 333-290793 | IPO Final prospectus | 2025-10-09 | 2025-11-06 | 3 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-04-24 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2044725/999999999526001330/9999999995-26-001330-index.htm) Declared effective | 333-295140 | 9999999995-26-001330 |
| 2026-04-17 | [S-1](https://www.sec.gov/Archives/edgar/data/2044725/000119312526161516/0001193125-26-161516-index.htm) Registration filed | 333-295140 | 0001193125-26-161516 |
| 2025-11-06 | [424B4](https://www.sec.gov/Archives/edgar/data/2044725/000119312525270066/0001193125-25-270066-index.htm) Final prospectus | 333-290793 | 0001193125-25-270066 |
| 2025-10-17 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2044725/000119312525242492/0001193125-25-242492-index.htm) Amendment | 333-290793 | 0001193125-25-242492 |
| 2025-10-09 | [S-1](https://www.sec.gov/Archives/edgar/data/2044725/000119312525235673/0001193125-25-235673-index.htm) Registration filed | 333-290793 | 0001193125-25-235673 |
| 2025-05-14 | [DRS](https://www.sec.gov/Archives/edgar/data/2044725/000095012325005244/0000950123-25-005244-index.htm) Draft made public | 377-08010 | 0000950123-25-005244 |

[All filings of this company](https://equitycapital.markets/filings?cik=2044725) · [CSV](https://equitycapital.markets/filings.csv?cik=2044725)

---
Source page: https://equitycapital.markets/company/2044725 · Data: U.S. SEC EDGAR · CC BY 4.0